First multicenter study for risk factors for hepatocellular carcinoma development in North Africa

World Journal of Hepatology

Volumn 3, Issue 1, 2011, Pages 24-30

  Bahri, Olfa ^a   Ezzikouri, Sayeh ^b   Alaya Bouafif, Ben ^a   Iguer, Fella ^c   El Feydi, Abdallah Essaid ^d   Mestiri, Hafedh ^e   Benazzouz, Moustapha ^d   Khalfallah, Tahar ^e   Afifi, Rajaa ^d   Elkihal, Latifa ^d   Berkane, Salah ^f   Marchio, Agnes ^h   Debzi, Nabil ^g   Dejean, Anne ^h   Pineau, Pascal ^h   Triki, Hinda ^a   Benjelloun, Soumaya ^b  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b Institut Pasteur du Maroc   (Morocco)

^c Institut Pasteur d'Algerie   (Algeria)

^d IBN SINA HOSPITAL   (Morocco)

^e MONGI SLIM HOSPITAL   (Tunisia)

^f CHU Oran   (Algeria)

^g CHU Mustapha   (Algeria)

^h INSERM   (France)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Non insulin dependent diabetes mellitus; North Africa

Indexed keywords

EID: 84866521374     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v3.i1.24     Document Type: Article

References (50)

1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-538
2. Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, Naramoto J. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000; 151: 131-139
3. Oyunsuren T, Kurbanov F, Tanaka Y, Elkady A, Sanduijav R, Khajidsuren O, Dagvadorj B, Mizokami M. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol 2006; 78: 1688-1695
4. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a casecontrol study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007; 22: 1104-1111
5. Levrero M. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 2006; 25: 3834-3847
6. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468
7. Chen CH, Huang GT, Yang PM, Chen PJ, Lai MY, Chen DS, Wang JD, Sheu JC. Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis. Eur J Cancer 2006; 42: 2524-2529
8. Merle P. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma]. Cancer Radiother 2005; 9: 452-457
9. Amarapurkar DN, Patel ND, Kamani PM. Impact of diabetes mellitus on outcome of HCC. Ann Hepatol 2008; 7: 148-151
10. Sebti MF. [Acute viral hepatitis and hepatitis B virus markers in chronic liver disease and primary cancer of the liver]. IARC Sci Publ 1984; 227-236
11. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bouguerra A, Hmida S, Dhahri R, Dellagi K. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 1997; 91: 11-1416
12. Benjelloun S, Bahbouhi B, Sekkat S, Bennani A, Hda N, Benslimane A. Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups. Res Virol 1996; 147: 247-255
13. Khalfa S, Ardjoun H. [Epidemiology of viral hepatitis in Algeria]. Med Trop (Mars) 1984; 44: 247-252
14. Ezzikouri S, Chemin I, Chafik A, Wakrim L, Nourlil J, Malki AE, Marchio A, Dejean A, Hassar M, Trepo C, Pineau P, Benjelloun S. Genotype determination in Moroccan hepatitis B chronic carriers. Infect Genet Evol 2008; 8: 306-312
15. Bouguerra R, Alberti H, Salem LB, Rayana CB, Atti JE, Gaigi S, Slama CB, Zouari B, Alberti K. The global diabetes pandemic: the Tunisian experience. Eur J Clin Nutr 2007; 61: 160-165
16. Tazi MA, Abir-Khalil S, Chaouki N, Cherqaoui S, Lahmouz F, Sraïri JE, Mahjour J. Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000. J Hypertens 2003; 21: 897-903
17. Malek R, Belateche F, Laouamri S, Hamdi-Cherif M, Touabti A, Bendib W, Nechadi A, Mekideche FZ, Hanat S. [Prevalence of type 2 diabetes mellitus and glucose intolerance in the Setif area (Algeria)]. Diabetes Metab 2001; 27: 164-171
18. Pineau P, Ezzikouri S, Marchio A, Benazzouz M, Cordina E, Afifi R, Elkihal L, Khalfallah MT, Mestiri H, Tebbal S, Berkane S, Debzi N, Triki H, Dejean A, Iguer F, Bahri O, Essaid El Feydi AE, Benjelloun S. Genomic stability prevails in North-African hepatocellular carcinomas. Dig Liver Dis 2007; 39: 671-677
19. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002; 36: S74-S83
20. Hassan MM, Frome A, Patt YZ, El-Serag HB. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 2002; 35: 266-269
21. el-Zayadi AR, Badran HM, Barakat EM, Attia Mel-D, Shawky S, Mohamed MK, Selim O, Saeid A. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol 2005; 11: 5193-5198
22. Uzunalimoglu O, Yurdaydin C, Cetinkaya H, Bozkaya H, Sahin T, Colakoglu S, Tankurt E, Sarioglu M, Ozenirler S, Akkiz H, Tözün N, Degertekin H, Okten A. Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci 2001; 46: 1022-1028
23. Ayoola EA, Gadour MO. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. J Gastroenterol Hepatol 2004; 19: 665-669
24. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Risk factors for hepatocellular carcinoma in Southern Iran. Saudi Med J 2005; 26: 974-977
25. Yaghi C, Sharara AI, Rassam P, Moucari R, Honein K, BouJaoude J, Slim R, Noun R, Abdul-Baki H, Khalifeh M, Ramia S, Sayegh R. Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival. World J Gastroenterol 2006; 12: 3575-3580
26. Alacacioglu A, Somali I, Simsek I, Astarcioglu I, Ozkan M, Camci C, Alkis N, Karaoglu A, Tarhan O, Unek T, Yilmaz U. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study. Jpn J Clin Oncol 2008; 38: 683-688
27. Triki H. [Epidemiology of hepatitis B virus, hepatitis C virus and Delta virus in the general population and in liver cirrhosis in Tunisia]. Arch Inst Pasteur Tunis 1994; 71: 403-406
28. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 2007; 96: 1127-1134
29. Gurtsevitch VE. Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc) 2008; 73: 504-513
30. Lotz G, Kiss A, Novák PK, Sobel G, Schaff Z. Hepatitis viruses and hepatocarcinogenesis. J Physiol Paris 2001; 95: 417-422
31. Hayashi J, Aoki H, Arakawa Y, Hino O. Hepatitis C virus and hepatocarcinogenesis. Intervirology 1999; 42: 205-210
32. Abe K, Edamoto Y, Park YN, Nomura AM, Taltavull TC, Tani M, Thung SN. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology 1998; 28: 568-572
33. Djebbi A, Triki H, Bahri O, Cheikh I, Sadraoui A, Ben Ammar A, Dellagi K. Genotypes of hepatitis C virus circulating in Tunisia. Epidemiol Infect 2003; 130: 501-505
34. Benani A, El-Turk J, Benjelloun S, Sekkat S, Nadifi S, Hda N, Benslimane A. HCV genotypes in Morocco. J Med Virol 1997; 52: 396-398
35. Abdo AA, Al-Jarallah BM, Sanai FM, Hersi AS, Al-Swat K, Azzam NA, Al-Dukhayil M, Al-Maarik A, Al-Faleh FZ. Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia. World J Gastroenterol 2006; 12: 7019-7024
36. Mojiri A, Behzad-Behbahani A, Saberifirozi M, Ardabili M, Beheshti M, Rahsaz M, Banihashemi M, Azarpira N, Geramizadeh B, Khadang B, Moaddeb A, Ghaedi M, Heidari T, Torab A, Salah A, Amirzadeh S, Jowkar Z, Mehrabani D, Amini-Bavil-Olyaee S, Dehyadegari MA. Hepatitis B virus genotypes in southwest Iran: molecular, serological and clinical outcomes. World J Gastroenterol 2008; 14: 1510-1513
37. Bahri O, Cheikh I, Hajji N, Djebbi A, Maamouri N, Sadraoui A, Mami NB, Triki H. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J Med Virol 2006; 78: 353-357
38. Ezzikouri S, Chemin I, Chafik A, Wakrim L, Nourlil J, Malki AE, Marchio A, Dejean A, Hassar M, Trepo C, Pineau P, Benjelloun S. Genotype determination in Moroccan hepatitis B chronic carriers. Infect Genet Evol 2008; 8: 306-312
39. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-1213
40. Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, Naramoto J. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000; 151: 131-139
41. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008; 47: 1856-1862
42. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-1219
43. Bahrami H, Daryani NE, Mirmomen S, Kamangar F, Haghpanah B, Djalili M. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol 2003; 3: 27
44. Adibi A, Janghorbani M, Shayganfar S, Amini M. First- degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease. Rev Diabet Stud 2007; 4: 236-241
45. Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, Abolghasemi H, Amini S, Maghsoudlu M, Deyhim MR, Rezvan H, Pourshams A. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol 2008; 14: 2867-2871
46. Judi L, Toukan A, Khader Y, Ajlouni K, Khatib MA. Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus. Ann Saudi Med 2010; 30: 25-32
47. Abdel WM, Mostafa M, Salah T, Fouud A, Kandeel T, Elshobary M, Abd Allah OF, Elghawalby N, Sultan A, Ezzat F. Epidemiology of hilar cholangiocarcinoma in Egypt: single center study. Hepatogastroenterology 2007; 54: 1626-1631
48. Singal AK, Ayoola AE. Prevalence and factors affecting occurrence of type 2 diabetes mellitus in Saudi patients with chronic liver disease. Saudi J Gastroenterol 2008; 14: 118-121
49. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127: 1372-1380
50. Kadri N, Agoub M, Assouab F, Tazi MA, Didouh A, Stewart R, Paes M, Toufiq J, Moussaoui D. Moroccan national study on prevalence of mental disorders: a community-based epidemiological study. Acta Psychiatr Scand 2010; 121: 71-74